Ratings for Itron ITRI were provided by 10 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 2 | 7 | 1 | 0 | 0 |
| Last 30D | 1 | 2 | 0 | 0 | 0 |
| 1M Ago | 1 | 1 | 0 | 0 | 0 |
| 2M Ago | 0 | 2 | 1 | 0 | 0 |
| 3M Ago | 0 | 2 | 0 | 0 | 0 |
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $106.6, along with a high estimate of $115.00 and a low estimate of $92.00. This upward trend is apparent, with the current average reflecting a 11.42% increase from the previous average price target of $95.67.
Diving into Analyst Ratings: An In-Depth Exploration
In examining recent analyst actions, we gain insights into how financial experts perceive Itron. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
| Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
|---|---|---|---|---|---|
| Chip Moore | Roth MKM | Raises | Buy | $112.00 | $102.00 |
| Kashy Harrison | Piper Sandler | Raises | Overweight | $109.00 | $103.00 |
| Noah Kaye | Oppenheimer | Raises | Outperform | $110.00 | $100.00 |
| Chip Moore | Roth MKM | Maintains | Buy | $102.00 | - |
| Kashy Harrison | Piper Sandler | Lowers | Overweight | $103.00 | $105.00 |
| Jeffrey Osborne | TD Cowen | Raises | Outperform | $110.00 | $107.00 |
| Ben Kallo | Baird | Raises | Outperform | $115.00 | $108.00 |
| Mark Strouse | JP Morgan | Raises | Neutral | $92.00 | $77.00 |
| Kashy Harrison | Piper Sandler | Raises | Overweight | $105.00 | $91.00 |
| Ben Kallo | Baird | Raises | Outperform | $108.00 | $68.00 |
Key Insights:
- Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Itron. This information offers a snapshot of how analysts perceive the current state of the company.
- Rating: Analysts assign qualitative assessments to stocks, ranging from 'Outperform' to 'Underperform'. These ratings convey the analysts' expectations for the relative performance of Itron compared to the broader market.
- Price Targets: Analysts set price targets as an estimate of a stock's future value. Comparing the current and prior price targets provides insight into how analysts' expectations have changed over time. This information can be valuable for investors seeking to understand consensus views on the stock's potential future performance.
Navigating through these analyst evaluations alongside other financial indicators can contribute to a holistic understanding of Itron's market standing. Stay informed and make data-driven decisions with our Ratings Table.
Stay up to date on Itron analyst ratings.
About Itron
Itron Inc provides solutions that measure, manage, and analyze energy and water use. It operates under the Itron brand and manages and reports under three operating segments: Device Solutions, Networked Solutions, and Outcomes. The device Solutions segment includes hardware products used for measurement, control, or sense that do not have communications capability embedded for use with broader Itron systems. The networked Solutions segment includes a combination of communicating devices, network infrastructure, and associated application software designed and sold as a complete solution. The outcome segment includes their value-added, enhanced software and services which manage, organize, analyze, and interpret data to improve decision-making and maximize operational profitability.
Understanding the Numbers: Itron's Finances
Market Capitalization Analysis: The company exhibits a lower market capitalization profile, positioning itself below industry averages. This suggests a smaller scale relative to peers.
Positive Revenue Trend: Examining Itron's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 23.46% as of 31 December, 2023, showcasing a substantial increase in top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Information Technology sector.
Net Margin: Itron's net margin excels beyond industry benchmarks, reaching 7.69%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): Itron's ROE excels beyond industry benchmarks, reaching 3.48%. This signifies robust financial management and efficient use of shareholder equity capital.
Return on Assets (ROA): Itron's ROA excels beyond industry benchmarks, reaching 1.74%. This signifies efficient management of assets and strong financial health.
Debt Management: Itron's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 0.37.
The Basics of Analyst Ratings
Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
If you want to keep track of which analysts are outperforming others, you can view updated analyst ratings along withanalyst success scores in Benzinga Pro.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
